Document Detail


Immunohistochemical analysis of human brain suggests pathological synergism of Alzheimer's disease and diabetes mellitus.
MedLine Citation:
PMID:  19778613     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It has been extensively reported that diabetes mellitus (DM) patients have a higher risk of developing Alzheimer's disease (AD), but a mechanistic connection between both pathologies has not been provided so far. Carbohydrate-derived advanced glycation endproducts (AGEs) have been implicated in the chronic complications of DM and have been reported to play an important role in the pathogenesis of AD. The earliest histopathological manifestation of AD is the apparition of extracellular aggregates of the amyloid beta peptide (Abeta). To investigate possible correlations between AGEs and Abeta aggregates with both pathologies, we have performed an immuhistochemical study in human post-mortem samples of AD, AD with diabetes (ADD), diabetic and nondemented controls. ADD brains showed increased number of Abeta dense plaques and receptor for AGEs (RAGE)-positive and Tau-positive cells, higher AGEs levels and major microglial activation, compared to AD brain. Our results indicate that ADD patients present a significant increase of cell damage through a RAGE-dependent mechanism, suggesting that AGEs may promote the generation of an oxidative stress vicious cycle, which can explain the severe progression of patients with both pathologies.
Authors:
Tony Valente; Alejandro Gella; Xavier Fern?ndez-Busquets; Mercedes Unzeta; Nuria Durany
Related Documents :
9574633 - Biology of neurological recovery and functional restoration after spinal cord injury.
9572283 - 3-hydroxybutyrate aids the recovery of the energy state from aglycaemic hypoxia of adul...
18594063 - Insulin resistance and hyperinsulinemia: you can't have one without the other.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-09-22
Journal Detail:
Title:  Neurobiology of disease     Volume:  37     ISSN:  1095-953X     ISO Abbreviation:  Neurobiol. Dis.     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2009-11-25     Completed Date:  2010-02-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9500169     Medline TA:  Neurobiol Dis     Country:  United States    
Other Details:
Languages:  eng     Pagination:  67-76     Citation Subset:  IM    
Affiliation:
Department of Biochemistry and Molecular Biology, School of Medicine, Neuroscience Institute, Autonomous University of Barcelona, Bellaterra-08193, Barcelona, Spain. tonyvalente@gmail.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Alzheimer Disease / metabolism*,  pathology
Amyloid beta-Protein / metabolism*
Brain / metabolism*,  pathology
Cell Count
Diabetes Mellitus / metabolism*,  pathology
Female
Fluorescent Antibody Technique
Glycosylation End Products, Advanced / metabolism*
Humans
Immunohistochemistry
Male
Microglia / metabolism,  pathology
Middle Aged
Peptide Fragments / metabolism*
Plant Lectins
Receptors, Immunologic / metabolism
Senile Plaques / metabolism,  pathology
Thiazoles
tau Proteins / metabolism
Chemical
Reg. No./Substance:
0/Amyloid beta-Protein; 0/Glycosylation End Products, Advanced; 0/MAPT protein, human; 0/Peptide Fragments; 0/Plant Lectins; 0/Receptors, Immunologic; 0/Thiazoles; 0/advanced glycosylation end-product receptor; 0/amyloid beta-protein (1-40); 0/tau Proteins; 0/tomato lectin; 2390-54-7/thioflavin T

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antioxidant effects of mycophenolate mofetil in a murine pleurisy model.
Next Document:  CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice.